Tag Archive for ‘ACS Clinical Research Program’
A summary of five ACS CRP Clinical Congress 2017 sessions is provided.
Gastric cancer is a significant cause of cancer morbidity and mortality in the U.S., with an estimated 26,370 new cases and 10,730 deaths in 2016.1 The incidence of gastric cancer is rising, particularly proximal tumors, and among young (< 40 years old) Caucasians, who have experienced a nearly 70 percent increase in the incidence of […]
The mission of the Dissemination and Implementation Committee—to provide surgeons with practice-changing results of the Alliance and other national clinical trial groups—is summarized.
Decision aids to enhance conversations with minority males entering prostate cancer treatment are described.
The Alliance for Clinical Trials in Oncology Foundation is accepting applications for the 2018 Alliance Scholar Awards.
Strategies for enhancing junior investigator participation in Alliance programs are highlighted.
The second volume of Operative Standards for Cancer Surgery, scheduled to be released in early 2017, describes operations for cancers of the esophagus, stomach, rectum, thyroid, and skin (melanoma).
Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC
Over the last three decades, there has been a significant shift in cancer care from the generalist to the specialist setting. This shift is especially true in surgical oncology, where surgeons specializing in the care of breast cancer, esophageal cancer, and pancreatic cancer have become the norm for many facilities treating cancer patients in the […]
The approach, aims, and eligibility criteria of the NRG Oncology TNT clinical trial are summarized.
This month’s column underscores the importance of clinical trial participation, in particular surgeons who have a demonstrated capability and knowledge in conducting research-related operations.
Pancreatic cancer is the fourth-most common cause of cancer-related death in the U.S. and is predicted to soon be the third-leading cause. Surgical resection with pancreatectomy has historically been viewed as offering the only chance for cure. However, achieving negative margins at surgery can be difficult, with positive surgical margins found in as many as […]
This month’s column describes the role of diet and lifestyle on the development and outcomes of prostate cancer, and includes a brief overview of published and ongoing trials.
Dissemination and implementation: Translating cancer guidelines and clinical trial outcomes into everyday practice
Dissemination strategies and implementation research programs, which examine how clinical trials data may be incorporated into clinical use, are the focus of this month’s column.
Operative Standards for Cancer Surgery, developed by the ACS Clinical Research Program Cancer Care Standards Development Committee, provides evidence-based guidelines for oncologic resections.
Experimental consideration confirming or refuting the impact of diet on cancer progression or its ability to protect consumers against carcinogenesis is needed, according to the authors of this month’s column. The Men’s Eating and Living study, which will follow prostate cancer patients under expectant management, will provide important data on the actual, short-term impact of the adoption of a diet that increases vegetable intake and limits meat and dairy intake.
American College of Surgeons Commission on Cancer Rapid Quality Reporting System: From quality measurement to quality improvement
Systems like the ACS Commission on Cancer’s Rapid Quality Reporting System (RQRS) not only measure quality, but also assist in immediate quality improvement. These systems, observes the author of this column, are valuable tools for improving cancer care and should be the focus of future research efforts.
To overcome inconsistencies in cancer care, the development, measurement, and reporting of quality measures are essential. This article highlights the efforts of the ACS Commission on Cancer and its collaboration with other societies involved in defining and measuring breast cancer care.
It is possible that the removal of additional lymph nodes may have only a small but beneficial therapeutic impact in patients with bladder cancer, according to the authors of this column, which highlights the critical role of lymphadenectomy as well as its limitations.
Our research shows tunneled pleural catheters are reliable methods to control malignant pleural effusion and may be optimal if full lung expansion is uncertain. This experience also suggested that a phased data gathering approach to better launch complex surgical trials and the selective use of alternative trial designs would enhance such future endeavors. This column highlights important lessons for future study.
The ACS Clinical Research Program (CRP) asserts that the time is right to develop a manual that provides details regarding surgical standards, complete with checklists. This article provides an overview of why such a manual is needed at this time and offers a call for volunteers to help in developing these guidelines.